rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Rezolute, Inc. - Common Stock (NV)

RZLT · Nasdaq

Health CareBiotechnologyJust dropped out

RZLT stood above a rising 150-day average in 17 of the last 52 weekly readings, and has been out of that trend for the last 1 week. It is 9.3% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).

Statistics

Rotation
Just dropped out
Weeks in an uptrend
out for 1
Industry in uptrend
18% -14 in 4 wk
Insider buys, 12 months
$264K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
138 (+20)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 17 of 52 weeks.

21 Apr – 20 Oct
18%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$3.9MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6
Sale orders, 12 months0
Buyers · sellers5 · 0
WhoDidSharesTraded
Daron EvansCFObought10,000at $2.8530 Mar 2026filed 31 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders138+20 on the quarter
New · exited38 · 18
Reported value$452.8M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
FEDERATED HERMES, INC.unchanged · filed 12 Aug 202612,990,659$67.6M00.0%
RA CAPITAL MANAGEMENT, L.P.added · filed 14 Aug 20269,445,039$49.1M+265,039+2.9%
BlackRock, Inc.added · filed 7 Aug 20267,718,291$40.1M+1,404,788+22.3%
Opaleye Management Inc.unchanged · filed 14 Aug 20266,300,000$32.8M00.0%
Balyasny Asset Management L.P.reduced · filed 14 Aug 20264,662,039$24.2M-386,382−7.7%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20263,835,827$19.9M+313,747+8.9%
Siren, L.L.C.unchanged · filed 13 Aug 20263,328,287$17.3M00.0%
JACOBS LEVY EQUITY MANAGEMENT, INCadded · filed 14 Aug 20262,561,654$13.3M+2,341,247+1062.2%
JENNISON ASSOCIATES LLCreduced · filed 3 Aug 20262,459,308$12.8M-979,573−28.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20262,170,154$11.3M+205,795+10.5%
31 Mar 2023 – 30 Jun 2026
3283134Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Sunil Ratilal Karnawat Company insiderChief Commercial Officer · last 2 Sep 20261 · 0
Brian Kenneth Roberts Company insiderChief Medical Officer · last 2 Jul 202616 · 0
Daron Evans Company insiderCFO · last 2 Jul 202613 · 0
Nevan C. Elam Company insiderCEO · last 2 Jul 20263 · 1
Wladimir Hogenhuis Company insiderDirector · last 16 Dec 20257 · 0
Erik Harris Company insiderDirector · last 19 Nov 20250 · 0
Gil M. Labrucherie Company insiderDirector · last 19 Nov 20252 · 0
Nerissa Kreher Company insiderDirector · last 19 Nov 20251 · 0
Philippe Fauchet Company insiderDirector · last 19 Nov 20250 · 0
Young-Jin Kim Company insiderDirector · last 19 Nov 20254 · 0
Handok, Inc. Company insiderDirector, 10% owner · last 22 Jul 202272 · 0
Keith A. Vendola Company insiderChief Financial Officer · last 31 Jul 20190 · 0

Same industry

MRNA ModernaLeading+167%
ENTX Entera BioLeading+52%
XNCR XencorLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2026 · to 30 Jun 2026-81.8%
Share count trendFY 2026 · to 21 Sep 20260.3%
Cash and equivalentsFY 2026 · to 30 Jun 2026$10.6M

Analyst forecasts

No analyst forecasts yet.